State Street’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

State Street’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-713,150	Closed	-$72.7M	–	4652
2023 Q2	$72.7M	Buy	713,150 +80,205	+13%	+$8.18M	﹤0.01%	1434
2023 Q1	$57.5M	Sell	632,945 -52,047	-8%	-$4.73M	﹤0.01%	1554
2022 Q4	$26M	Sell	684,992 -66,251	-9%	-$2.52M	﹤0.01%	2049
2022 Q3	$18.9M	Buy	751,243 +9,530	+1%	+$239K	﹤0.01%	2274
2022 Q2	$22.5M	Buy	741,713 +73,695	+11%	+$2.24M	﹤0.01%	2164
2022 Q1	$21.9M	Sell	668,018 -596	-0.1%	-$19.5K	﹤0.01%	2329
2021 Q4	$17.6M	Buy	668,614 +44,658	+7%	+$1.18M	﹤0.01%	2567
2021 Q3	$62.8M	Buy	623,956 +34,467	+6%	+$3.47M	﹤0.01%	1632
2021 Q2	$83.4M	Buy	589,489 +209,100	+55%	+$29.6M	﹤0.01%	1440
2021 Q1	$37.9M	Sell	380,389 -2,870	-0.7%	-$286K	﹤0.01%	1946
2020 Q4	$47.4M	Sell	383,259 -4,023	-1%	-$497K	﹤0.01%	1668
2020 Q3	$37.7M	Buy	387,282 +26,005	+7%	+$2.53M	﹤0.01%	1651
2020 Q2	$56.4M	Sell	361,277 -156,888	-30%	-$24.5M	﹤0.01%	1380
2020 Q1	$74.8M	Buy	518,165 +7,394	+1%	+$1.07M	0.01%	1007
2019 Q4	$104M	Buy	510,771 +46,003	+10%	+$9.4M	0.01%	1022
2019 Q3	$37.3M	Buy	464,768 +6,728	+1%	+$540K	﹤0.01%	1645
2019 Q2	$43.2M	Buy	458,040 +32,683	+8%	+$3.08M	﹤0.01%	1574
2019 Q1	$36.4M	Sell	425,357 -19,763	-4%	-$1.69M	﹤0.01%	1641
2018 Q4	$25M	Buy	445,120 +38,018	+9%	+$2.13M	﹤0.01%	1835
2018 Q3	$33.3M	Buy	407,102 +89,891	+28%	+$7.35M	﹤0.01%	1821
2018 Q2	$11.1M	Buy	317,211 +130,614	+70%	+$4.57M	﹤0.01%	2489
2018 Q1	$3.83M	Buy	186,597 +8,629	+5%	+$177K	﹤0.01%	2922
2017 Q4	$5.04M	Buy	177,968 +35,521	+25%	+$1.01M	﹤0.01%	2788
2017 Q3	$4.43M	Buy	142,447 +34,235	+32%	+$1.06M	﹤0.01%	2856
2017 Q2	$3.42M	Buy	108,212 +5,094	+5%	+$161K	﹤0.01%	2922
2017 Q1	$2.34M	Buy	103,118 +2,704	+3%	+$61.3K	﹤0.01%	3025
2016 Q4	$2.19M	Buy	100,414 +4,879	+5%	+$106K	﹤0.01%	3070
2016 Q3	$2.52M	Buy	95,535 +32,124	+51%	+$846K	﹤0.01%	2883
2016 Q2	$1.25M	Buy	+63,411	New	+$1.25M	﹤0.01%	3204